Posts Tagged ‘California Biotech Law Blog’

IPO Outlook for Biotech Remains Dreary in 2012

Thursday, February 16th, 2012

The California Biotech Law Blog reported that the outlook for biotech in 2012 was expected to remain dreary, and that companies would continue to focus on acquisitions over IPOs in the following blog post:

 http://californiabiotechlaw.com/archives/biotech-ipos/ipo-outlook-for-biotech-remains-dreary-in-2012/

Is the Passage of Patent Reform a Win for the Biotech Industry?

Sunday, September 25th, 2011

The California Biotech Law Blog looked at the issue of how patent reform would affect the biotech industry in the following blog post link:

 http://californiabiotechlaw.com/archives/biotech-legislative-developments/the-passage-of-patent-reform-is-this-really-a-win-for-the-biotech-industry/

What does Patent Reform Mean for Silicon Valley?

Sunday, September 25th, 2011

The Silicon Valley IP Licensing Law Blog discussed the passage of the Patent Reform Bill and explored its significance to Silicon Valley in the following blog post link below:

http://www.siliconvalleyiplicensinglaw.com/what-does-patent-reform-mean-for-silicon-valley-entrepreneurs/

Fourteen States Launch Constitutional Challenge to Health Care Reform Bill

Wednesday, March 24th, 2010

The California Biotech Law Blog discussed the constitutional arguments at issue in the challenge posed to the health care reform bill in the following blog post:

http://californiabiotechlaw.com/archives/biotech-legislative-developments/fourteen-states-launch-constitutional-challenge-to-health-care-reform-bill/

Biotech Industry Evaluates Anticipated Impact of Health Care Reform

Monday, March 22nd, 2010

How is the biotech industry reacting to the passage of health care reform?  The California Biotech Law Blog explored the industry reaction in the following blog post:

http://californiabiotechlaw.com/archives/biotech-legislative-developments/biotech-industry-evaluates-anticipated-impact-of-health-care-reform/

California Biotech Law Blog Named Top 50 Biotech Blog

Wednesday, March 3rd, 2010

The Prinz Law Office is pleased to announce that the California Biotech Law Blog has been named to a list of Top 50 Biotech Blogs. 

Click here to read story.

California Biotech Law Blog Recognized as Top 50 Biotech Blog

Wednesday, March 3rd, 2010

The California Biotech Law Blog announced that the blog has been recognized as a top 50 biotech blog in the following blog post:

http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/california-biotech-law-blog-named-to-list-of-top-50-biotech-blogs/

Patrick Reilly of IP Society Interviews Silicon Valley Biotech Licensing Lawyer Kristie Prinz

Saturday, February 27th, 2010

Patrick Reilly of IP Society interviewed Silicon Valley biotech licensing lawyer Kristie Prinz, as reported in the following blog post:

http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/patrick-reilly-of-ip-society-interviews-california-biotech-law-blogs-kristie-prinz/

The SciTech Lawyer Profiles Silicon Valley Biotech Transactions Lawyer Kristie Prinz

Friday, February 19th, 2010

The California Biotech Law Blog reported on The SciTech Lawyer’s profile story on Silicon Valley Biotech Transactions Lawyer Kristie Prinz in the following blog post:

http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/thescitechlawyer-profiles-california-biotech-law-blogs-kristie-prinz/

Kristie Prinz Interviewed by Technology Transfer Tactics on Issue of Whether Poster Presentations Jeopardize a TTO’s Commercialization Efforts

Friday, February 12th, 2010

Do poster presentations jeopardize a tech transfer office’s commercialization efforts?  The California Biotech Law Blog reported on Technology Transfer Tactics’ interview of Silicon Valley Lawyer Kristie Prinz on this issue at the following blog post:

http://californiabiotechlaw.com/archives/biotech-blog-in-the-news/kristie-prinz-interviewed-by-technology-transfer-tactics-on-issue-of-whether-poster-presentations-jeopardize-a-ttos-commercialization-efforts/

Seventh Circuit Rules in favor of WARF in Licensing Dispute with Xenon Pharmaceuticals

Thursday, January 14th, 2010

The Seventh Circuit Court of Appeals has ruled in favor of WARF in its licensing dispute with Xenon Pharmaceuticals, as reported by the California Biotech Law Blog in the following blog post:

http://californiabiotechlaw.com/archives/biotech-deals/seventh-circuit-rules-in-favor-of-warf-in-licensing-dispute-with-xenon-pharmaceuticals-case/

SBIR Reauthorization Effort At a Standstill

Tuesday, January 12th, 2010

The California Biotech Law Blog explored the issues delaying SBIR reauthorization in the following blog post:

http://californiabiotechlaw.com/archives/biotech-legislative-developments/sbir-reauthorization-effort-continues-to-be-at-standstill/

California Lawyer Reporter Jeanette Borzo Interviews Internet Lawyer Kristie Prinz in “The Search for Intelligent Life in the Blogosphere”

Thursday, May 1st, 2008

Click here to read interview.

LexBlog’s Kevin O’Keefe Profiles Silicon Valley Lawyer Kristie Prinz and The California Biotech Law Blog in “Be An A-List Blogger in Your Niche to Succeed”

Tuesday, March 27th, 2007

Click here to read the article.

image_pdfimage_print

| The Prinz Law Office | Silicon Valley •2021 The Alameda, San Jose, CA 95126 • Mailing Address Silicon Valley: 117 Bernal Rd., Suite 70-110, San Jose, CA 95119 •408.884.2854 | San Francisco▪ 4 Embarcadero Center, San Francisco, CA 94111▪415.874.8584 | Los Angeles▪310.907.9218 | Orange County: 100 Spectrum Center Drive 9th Floor Irvine, CA 92618 ▪949.284.6884 | San Diego ▪619.881.0424 | Tel: 1.800.884.2124 |

Web Development by Axis Media

Portions of this website may include what may be considered ATTORNEY ADVERTISING in some states. Please note that any discussion on this website of prior results does not guarantee similar outcomes

Prinz Law Office | Silicon Valley SaaS, Technology & IP Law Firm & Lawyers